GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » GlucoTrack Inc (NAS:GCTK) » Definitions » E10

GCTK (GlucoTrack) E10 : $-1,522.23 (As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is GlucoTrack E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

GlucoTrack's adjusted earnings per share data for the three months ended in Sep. 2024 was $-18.200. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-1,522.23 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average E10 Growth Rate was 5.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of GlucoTrack was 5.20% per year. The lowest was 5.20% per year. And the median was 5.20% per year.

As of today (2025-03-14), GlucoTrack's current stock price is $0.365. GlucoTrack's E10 for the quarter that ended in Sep. 2024 was $-1,522.23. GlucoTrack's Shiller PE Ratio of today is .


GlucoTrack E10 Historical Data

The historical data trend for GlucoTrack's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlucoTrack E10 Chart

GlucoTrack Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -1,642.31 -1,654.58 -1,677.06 -1,399.68

GlucoTrack Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,648.92 -1,399.68 -1,398.88 -1,542.43 -1,522.23

Competitive Comparison of GlucoTrack's E10

For the Medical Instruments & Supplies subindustry, GlucoTrack's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlucoTrack's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, GlucoTrack's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where GlucoTrack's Shiller PE Ratio falls into.



GlucoTrack E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, GlucoTrack's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-18.2/133.0289*133.0289
=-18.200

Current CPI (Sep. 2024) = 133.0289.

GlucoTrack Quarterly Data

per share eps CPI Adj_EPS
201412 -195.000 99.070 -261.842
201503 -403.000 99.621 -538.146
201506 -429.000 100.684 -566.818
201509 -286.000 100.392 -378.979
201512 -390.000 99.792 -519.892
201603 -312.000 100.470 -413.107
201606 -390.000 101.688 -510.200
201609 -390.000 101.861 -509.334
201612 -312.000 101.863 -407.460
201703 -624.001 102.862 -807.004
201706 -624.001 103.349 -803.202
201709 -572.001 104.136 -730.707
201712 -611.001 104.011 -781.463
201803 -442.000 105.290 -558.449
201806 -429.000 106.317 -536.786
201809 -403.000 106.507 -503.355
201812 -4,914.005 105.998 -6,167.147
201903 -13.000 107.251 -16.125
201906 -13.000 108.070 -16.002
201909 -13.000 108.329 -15.964
201912 -13.000 108.420 -15.951
202003 -5.249 108.902 -6.412
202006 -3.999 108.767 -4.891
202009 -3.000 109.815 -3.634
202012 -5.691 109.897 -6.889
202103 -6.000 111.754 -7.142
202106 -6.000 114.631 -6.963
202109 -5.000 115.734 -5.747
202112 -9.000 117.630 -10.178
202203 -7.000 121.301 -7.677
202206 -7.000 125.017 -7.449
202209 -6.000 125.227 -6.374
202212 -9.000 125.222 -9.561
202303 -8.000 127.348 -8.357
202306 -5.400 128.729 -5.580
202309 -9.800 129.860 -10.039
202312 -10.400 129.419 -10.690
202403 -12.000 131.776 -12.114
202406 -16.400 132.554 -16.459
202409 -18.200 133.029 -18.200

Add all the adjusted EPS together and divide 10 will get our e10.


GlucoTrack  (NAS:GCTK) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


GlucoTrack E10 Related Terms

Thank you for viewing the detailed overview of GlucoTrack's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


GlucoTrack Business Description

Traded in Other Exchanges
N/A
Address
301 Route 17 North, Suite 800, Rutherford, New Jersey, NJ, USA, 07070
GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.
Executives
Drew Sycoff director C/O ANDREW GARRETT INC, 52 VANDERBILT AVENUE - 20TH FLOOR, NEW YORK NY 10017
James S Cardwell officer: Chief Financial Officer CLINTON SQUARE, 75 S. CLINTON AVE., SUITE 510, ROCHESTER NY 14604
Erin Catherine Carter director 301 RTE 17 NORTH, STE. 800, RUTHERFORD NJ 07070
Allen Danzig director 301 RT 17 NORTH, SUITE 800, RUTHERFORD NJ 07070
Shimon D Rapps director C/O ANDREW GARRETT, INC., 52 VANDERBILT AVENUE SUITE 510, NEW YORK NY 10017
David Podwalski officer: Chief Commercial Officer 19 HA'YAHALOMIM ST., P.O. BOX 12163, ASHDOD L3 7760049
Michael Hauck director 19 HA'YAHALOMIM ST., P.O. BOX 12163, C/O INTEGRITY APPLICATIONS, INC., ASHDOD L3 7760049
John A Graham director, officer: Chief Executive Officer 19 HA'YAHALOMIM STREET, P.O. BOX 12163, ASHDOD L3 7760049
Sami Sassoun officer: Chief Financial Officer 39-06 ACKERMAN DRIVE, FAIR LAWN L3 7760049
Philip Darivoff director 1 FARMSTEAD ROAD, SHORT HILLS NJ 07078
Revan Schwartz director 19 HA'YAHALOMIM ST., P.O. BOX 12163, C/O INTEGRITY APPLICATIONS, INC., ASHDOD L3 7760049
Leslie Seff director PO BOX 59, 40 HELLBROOK LANE, ULSTER PARK NY 12487
Angela Strand Boydston director C/O AEROGEN, INC., 2071 STIERLIN COURT, MOUNTAIN VIEW CA 94043
Eran Hertz officer: Chief Financial Officer C/O INTEGRITY APPLICATIONS, INC., 102 HA'AVODA STREET, P.O. BOX 432, ASHKELON L3 L3 78100
Israel B. Ehrlich director C/O INTEGRITY APPLICATIONS, INC., 102 HA'AVODA STREET, P.O. BOX 432, ASHKELON L3 L378100